Silicon Valley’s notorious biotech entrepreneur Elizabeth Holmes started serving an 11-year sentence in a Texas federal jail this week, marking what appears to be like like the ultimate act of Theranos’ dramatic downfall.

Her firm promised revolutionary blood-testing know-how that was in the end revealed to be non-existent. Patrick O’Neill, the previous chief inventive officer at Theranos, mirrored on his expertise working with Holmes in an as-told-to essay with Enterprise Insider; this is what O’Neill’s expertise was like.

The Starting: Holmes approached O’Neill’s promoting company, TBWA/Chiat/Day, in 2012 with the will to construct the Theranos model, mirroring the type of Apple Inc AAPL, a transfer that intrigued the O’Neill and his staff.

For him, working with an unknown model that aimed to disrupt the healthcare business was a chance, to not point out the rarity of collaborating with a feminine founder in Silicon Valley.

Holmes, very similar to Apple founder Steve Jobs, most well-liked to work beneath a veil of secrecy, which wasn’t uncommon to O’Neill. He described Holmes as a superb visionary whose quirks and relentless deal with her mission confirmed his optimistic picture of her.

Ultimately, Holmes invited O’Neill to hitch Theranos as chief inventive officer in 2014, a proposal he accepted, anticipating the possibility to contribute to an organization with an influential mission.

The primary 12 months at Theranos was a hit, O’Neill stated, from incomes FDA approval to celebrating Holmes’ function on the quilt of Forbes because the youngest self-made feminine billionaire.

Although, he stated issues took a flip in 2015 when The Wall Road Journal issued its damning article criticizing Theranos’ lab checks.

Within the ensuing chaos, O’Neill stated Holmes spun a story of being focused by the healthcare-industrial complicated, the media and skeptics, a story O’Neill and lots of others purchased into.

As time handed, a barrage of accusations turned the brand new regular on the firm, O’Neill stated. Holmes would frequently deal with criticisms in company-wide city halls, sustaining a defiant stance and spinning every assault as an inevitable a part of groundbreaking work.

The rising unease peaked when Theranos labs and wellness facilities in Arizona shut down in July 2016, adopted by sweeping layoffs in October, leaving O’Neill as one of many few remaining members of the inventive staff.

By 2017, O’Neill left Theranos, struggling to reconcile the idealized view he had of the corporate with the rising actuality.

Reflecting on his time at Theranos, the previous chief inventive officer stated he realized to be extra skeptical and developed a deep-seated mistrust for the “faux it till you make it” mentality typically propagated in Silicon Valley.

Learn Subsequent: Awkward Rewind: When Jim Cramer Known as Elizabeth Holmes The Subsequent Steve Jobs On TV

Images: Shutterstock